22157.jpg
Global Human Gene Sequencing Markets, Strategies, Trends, and Recent Industry Developments 2023-2027
January 15, 2024 13:23 ET | Research and Markets
Dublin, Jan. 15, 2024 (GLOBE NEWSWIRE) -- The "Human Gene Sequencing Markets, Strategies & Trends - Forecasts by Application, by Technology, by Workflow, by Product, and by Country, with...
logo.png
Liquid Biopsy Market Size to Reach USD 18,280.13 Million by 2032
December 27, 2023 11:00 ET | Precedence Research
Ottawa, Dec. 27, 2023 (GLOBE NEWSWIRE) -- The global liquid biopsy market size was valued at USD 5,397.61 million in 2023, grew to USD 6,171.08 million in 2024 and the sector is expanding at a...
Emergen logo.png
Global Minimal Residual Disease (MRD) Market Size to Reach USD 4,138.5 Million in 2030 | Emergen Research
September 14, 2023 09:51 ET | Emergen Research
Vancouver, Sept. 14, 2023 (GLOBE NEWSWIRE) -- The global Minimal Residual Disease (MRD) market size was USD 1,095.3 Million in 2021 and is expected to register a revenue CAGR of 16.04% during the...
website-logo (2).png
Breast Cancer Liquid Biopsy Market Rising at 22.6% CAGR; Expected to Reach US$ 2.7 Bn by 2032 | MarketResearch.biz
July 17, 2023 09:04 ET | MarketResearch.biz
New York, July 17, 2023 (GLOBE NEWSWIRE) -- Global Breast Cancer Liquid Biopsy Market size accounted for USD 0.4 Bn in 2022. It is projected to surpass around USD 2.7 Bn by 2032, and it is poised to...
PharmEnable
PharmEnable Closes $7.5M Financing led by MP Healthcare to Develop Next Generation of Small Molecule Drugs to Treat Cancer and Neurological Diseases
May 22, 2023 04:00 ET | PharmEnable
$7.5M Pre-Series A financing led by new investor MP Healthcare, the venture arm of Mitsubishi Tanabe Pharma Group. Existing investors Cambridge Enterprise, University of Cambridge Enterprise Fund...
Logo.png
The Global Blood Cancer Diagnostics Market is Expected to Showcase a Significant Growth at a CAGR of ~6% by 2027 | DelveInsight
March 09, 2023 13:00 ET | DelveInsight Business Research LLP
New York, USA, March 09, 2023 (GLOBE NEWSWIRE) -- The Global Blood Cancer Diagnostics Market is Expected to Showcase a Significant Growth at a CAGR of ~6% by 2027 | DelveInsight The blood cancer...
Global Minimal Residual Disease Market
Minimal Residual Disease Global Market Report 2023: Growing Investment For Research Presents Opportunities
February 21, 2023 05:38 ET | Research and Markets
Dublin, Feb. 21, 2023 (GLOBE NEWSWIRE) -- The "Minimal Residual Disease Market Share, Size, Trends, Industry Analysis Report, By Detection Target (Lymphoma, Leukemia, Solid Tumors, Others); By Test...
22157.jpg
Global Liquid Biopsy Markets Report 2023: Cancer, Usage, Biomarker, Place, & Products Analysis with Price and Volume Outlook to 2027
February 08, 2023 09:18 ET | Research and Markets
Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The "Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, & Product With Price and Volume Outlook. Including Executive and Consultant Guides and...
MaximizeMarketResearch
Lung Cancer Screening Market Worth USD 4.13 Bn by 2029 Technological advancement, and key benchmarking of market players
January 18, 2023 03:16 ET | MAXIMIZE MARKET RESEARCH PRIVATE LIMITED
Portland, Jan. 18, 2023 (GLOBE NEWSWIRE) -- According to the "Lung Cancer Screening Market" research published by Maximize Market Research, the market is expected to grow from USD 2.18 billion in...
DBMR Logo.png
Melanoma Cancer Diagnostics Market to Observe Highest Growth of USD 7,525.28 Million with Excellent CAGR of 7.2% in the Forecast Period of 2023 to 2030
January 03, 2023 16:30 ET | Data Bridge Market Research
SYDNEY, Jan. 03, 2023 (GLOBE NEWSWIRE) -- "Melanoma Cancer Diagnostics Market" is the title of a new report from Data Bridge Market Research. Key growth strategies, drivers, opportunities, key...